We analyzed copy number alterations, mutations, methylations, and mRNA expressions of ID 1–4 and E2A using The Cancer Genome Atlas data of 570 ovarian serous cystadenocarcinoma patients. The gene discussed is ID1; the disease is ovarian serous cystadenocarcinoma.